11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial
Resource Type
Article
Authors
Cameron, David ; Piccart-Gebhart, Martine J ; Gelber, Richard D ; Procter, Marion ; Goldhirsch, Aron ; de Azambuja, Evandro ; Castro, Gilberto, Jr ; Untch, Michael ; Smith, Ian ; Gianni, Luca ; Baselga, Jose ; Al-Sakaff, Nedal ; Lauer, Sabine ; McFadden, Eleanor ; Leyland-Jones, Brian ; Bell, Richard ; Dowsett, Mitch ; Jackisch, Christian
Source
In The Lancet 25-31 March 2017 389(10075):1195-1205
Subject
Primary Research Articles
Language
ISSN
0140-6736